Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,480 | 22,590 | 26,080 | 28,560 | 8,780 |
| Marketable Securities | 3,470 | 1,630 | 1,610 | 1,470 | 0 |
| Receivables | 20 | 50 | 30 | 50 | 50 |
| Other current assets | 500 | 710 | 410 | 460 | 290 |
| TOTAL | $19,470 | $24,980 | $28,130 | $30,540 | $9,120 |
| Non-Current Assets | |||||
| Investments And Advances | 650 | 660 | 650 | 600 | 0 |
| TOTAL | $650 | $660 | $650 | $600 | $N/A |
| Total Assets | $20,330 | $25,860 | $28,980 | $31,330 | $9,320 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,740 | 3,540 | 2,810 | 3,720 | 2,830 |
| TOTAL | $1,740 | $3,540 | $2,810 | $3,720 | $2,830 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,740 | $3,540 | $2,810 | $3,720 | $2,830 |
| Shareholders' Equity | |||||
| Common Shares | 127,000 | 128,480 | 126,760 | 116,110 | 93,340 |
| Retained earnings | -126,320 | -123,900 | -118,130 | -104,560 | -103,360 |
| Other shareholders' equity | 1,990 | 2,020 | 1,990 | 3,970 | 4,330 |
| TOTAL | $18,590 | $22,320 | $26,160 | $27,610 | $6,480 |
| Total Liabilities And Equity | $20,330 | $25,860 | $28,970 | $31,330 | $9,310 |